Holen Sie sich die Stockscreener-App
73.98
0.36%
-0.2313
Schlusskurs vom Vortag:
$74.21
Offen:
$74.25
24-Stunden-Volumen:
671.71K
Relative Volume:
0.46
Marktkapitalisierung:
$8.42B
Einnahmen:
$13.18B
Nettoeinkommen (Verlust:
$419.00M
KGV:
22.62
EPS:
3.2704
Netto-Cashflow:
$521.00M
1W Leistung:
+1.41%
1M Leistung:
-4.64%
6M Leistung:
-1.73%
1J Leistung:
+3.20%
1-Tages-Spanne:
$73.60
$74.51
1-Wochen-Bereich:
$71.66
$74.81
52-Wochen-Spanne:
$61.95
$89.29
Henry Schein Inc Stock (HSIC) Company Profile
Firmenname
Henry Schein Inc
Sektor
Branche
Telefon
(631) 843-5500
Adresse
135 DURYEA RD, MELVILLE, NY
Compare HSIC vs MCK, COR, CAH, AHG
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HSIC
Henry Schein Inc
|
73.94 | 8.45B | 13.18B | 419.00M | 521.00M | 3.2704 |
MCK
Mckesson Corp
|
753.50 | 92.09B | 403.43B | 5.10B | 5.41B | 38.47 |
COR
Cencora Inc
|
271.96 | 53.49B | 328.68B | 2.55B | 1.56B | 13.03 |
CAH
Cardinal Health Inc
|
201.05 | 47.00B | 250.74B | 1.55B | 4.39B | 6.5398 |
AHG
Akso Health Group Adr
|
1.615 | 1.31B | 14.85M | -136.07M | 7.25M | -0.4726 |
Henry Schein Inc Stock (HSIC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-16 | Eingeleitet | BTIG Research | Neutral |
| 2026-04-15 | Eingeleitet | Citigroup | Buy |
| 2026-02-23 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-08-26 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-07-25 | Herabstufung | Stifel | Buy → Hold |
| 2025-07-14 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-02-14 | Eingeleitet | Wells Fargo | Equal Weight |
| 2025-01-06 | Hochstufung | BofA Securities | Underperform → Buy |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-07-22 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2023-12-12 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-11-10 | Hochstufung | Stifel | Hold → Buy |
| 2022-08-08 | Hochstufung | UBS | Sell → Neutral |
| 2022-07-21 | Herabstufung | Goldman | Buy → Neutral |
| 2022-06-14 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-05-13 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-01-31 | Eingeleitet | Morgan Stanley | Underweight |
| 2022-01-07 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2021-10-01 | Fortgesetzt | Credit Suisse | Neutral |
| 2021-02-08 | Fortgesetzt | Piper Sandler | Overweight |
| 2021-01-04 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-11-03 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2020-05-06 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2020-04-07 | Hochstufung | Goldman | Neutral → Buy |
| 2020-04-02 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-01-09 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2020-01-02 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2019-08-07 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2019-05-30 | Eingeleitet | Wolfe Research | Underperform |
| 2019-05-15 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2019-04-18 | Eingeleitet | Guggenheim | Buy |
| 2019-01-17 | Eingeleitet | UBS | Sell |
| 2019-01-03 | Herabstufung | Evercore ISI | In-line → Underperform |
| 2019-01-02 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2018-11-08 | Bestätigt | Barrington Research | Outperform |
| 2018-10-25 | Herabstufung | Edward Jones | Hold → Sell |
| 2018-10-19 | Fortgesetzt | Goldman | Neutral |
| 2018-10-04 | Bestätigt | Robert W. Baird | Outperform |
| 2018-08-07 | Bestätigt | Stifel | Hold |
| 2018-04-24 | Herabstufung | Goldman | Buy → Neutral |
| 2018-04-04 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
Alle ansehen
Henry Schein Inc Aktie (HSIC) Neueste Nachrichten
Henry Schein stock (US42548G1040): Dental and medical distributor navigates shifting US healthcare d - AD HOC NEWS
Henry Schein stock: Is Wall Street bullish or bearish? - MSN
Henry Schein, Inc. (HSIC) Stock Analysis: Healthcare Distributor with 17.52% Potential Upside - DirectorsTalk Interviews
Henry Schein highlights dental momentum, $125M savings goal despite medical softness - MSN
Henry Schein appoints William Daniel as independent chairman - Investing.com UK
Henry Schein (HSIC) director reports bona fide 50-share stock gift - Stock Titan
Henry Schein Elects William K. “Dan” Daniel as Independent Chairman of the Board, Succeeding Stan Bergman After 44 Years - Minichart
Henry Schein appoints William Daniel as independent chairman By Investing.com - Investing.com South Africa
Henry Schein, Inc. (HSIC) Announces Key Decisions from 2026 Annu - GuruFocus
Here's Why Henry Schein (HSIC) is a Strong Value Stock - Yahoo Finance
Henry Schein Names William K. Daniel as Independent Chairman - Moomoo
Henry Schein Names New Board Chairman - Dentistry Today
Henry Schein announces the election of William K. "Dan" Daniel as independent chairman of the board - marketscreener.com
Dan Daniel becomes Henry Schein (HSIC) independent chair as Bergman retires - Stock Titan
Declaration of Voting Results by Henry Schein - marketscreener.com
Henry Schein Governance Push Meets Discounted Valuation And Mixed Share Performance - Sahm
Henry Schein (HSIC) director Stanley Bergman gifts 1,040 shares - Stock Titan
Henry Schein stock (US42548G1040): Q1 2026 results and outlook update put margins in the spotlight - AD HOC NEWS
Assessing Henry Schein (HSIC) Valuation After Recent Uneven Share Price Performance - Yahoo Finance
Henry Schein Stock: Is Wall Street Bullish or Bearish? - Barchart.com
Henry Schein stock (US42548G1040): Q1 results and outlook update draw investor focus - AD HOC NEWS
Henry Schein, Inc. (HSIC) Stock Analysis: Exploring a 19.93% Potential Upside in Medical Distribution - DirectorsTalk Interviews
Henry Schein Highlights Dental Momentum, $125M Savings Goal Despite Medical Softness - MarketBeat
A Look At Henry Schein (HSIC) Valuation After Solid Q1 Update And Reaffirmed Guidance - Sahm
Why Henry Schein (HSIC) is a top value stock for the long term - MSN
Citigroup initiates coverage of Henry Schein (HSIC) with buy recommendation - MSN
Analysts Offer Insights on Healthcare Companies: Henry Schein (HSIC), Insulet (PODD) and Gilead Sciences (GILD) - The Globe and Mail
LONE PEAK VALUE FUND's Henry Schein Inc(HSIC) Holding History - GuruFocus
An Insider Of Henry Schein Picks Up 100% More Stock - simplywall.st
5 Must-Read Analyst Questions From Henry Schein’s Q1 Earnings Call - Yahoo Finance
Henry Schein Inc (HSIC) Stock Up 4.5% and Still Undervalued -- G - GuruFocus
Henry Schein Inc. stock outperforms competitors on strong trading day - MarketWatch
Henry Schein One Releases 2026 Catalyst Index - Dentistry Today
Henry Schein One Releases 2026 Catalyst Index, Revealing Clinical Performance as the Primary Driver of Growth - 01net
Henry Schein (HSIC) director boosts stake with 10,000-share open-market buy via trust - Stock Titan
Henry Schein beats Q1 earnings with $1.32 EPS, 6.3% revenue growth - eciks.org
Henry Schein : 2026 Proxy Supplement May 12, 2026 of 2025 - marketscreener.com
Right to Read, but Wrong to Write - Health API Guy
Henry Schein Inc. stock underperforms Monday when compared to competitors - MarketWatch
Henry Schein, Inc. $HSIC Holdings Increased by Mitsubishi UFJ Asset Management Co. Ltd. - MarketBeat
Henry Schein stock (US42548G1040): Dental and medical distributor reports Q1 results and raises outl - AD HOC NEWS
Henry Schein stock (US42548G1040): Q1 2026 results and buyback drive sentiment - AD HOC NEWS
Barclays Maintains Henry Schein(HSIC.US) With Buy Rating, Maintains Target Price $86 - Moomoo
Henry Schein tops expectations, but shares dip slightly after results - MSN
Henry Schein Inc stock (US8064071025): Dental and medical distributor reports Q1 results and raises - AD HOC NEWS
Henry Schein, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions - Moomoo
Henry Schein, Inc. Just Recorded A 8.1% EPS Beat: Here's What Analysts Are Forecasting Next - simplywall.st
Earnings Beat: Henry Schein, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models - Yahoo Finance
Henry Schein Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Analysts Are Bullish on Top Healthcare Stocks: Henry Schein (HSIC), Alphatec Holdings (ATEC) - The Globe and Mail
Number of shareholders of Henry Schein, Inc. – MIL:1HSIC - TradingView
Finanzdaten der Henry Schein Inc-Aktie (HSIC)
Umsatz
Nettogewinn
Free Cashflow
ENV
6.29%
2.28%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):